Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Drugmaker Shire to buy Baxalta for $32 billion after six-month pursuit
-
-
-
-
-
-
-
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
-
-
-
-
-
-
-
Deutsche Bank Resumes Shire (SHPG) at Buy
-
-
-
-
-
-
-
ViroPharma (VPHM) Fair Value $46-$52 in M&A Scenarios - Deutsche Bank
55,244 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

